Brief: Medincell Initiates First Clinical Trial Of Its Covid-19 Prevention Program

Medincell SA

29/09/2020 17:10

Sept 29 (Reuters) - MEDINCELL SA  MEDCL.PA :
    * MEDINCELL INITIATES FIRST CLINICAL TRIAL OF ITS COVID-19
PREVENTION PROGRAM 09.29.2020
    * MEDINCELL MAY FILE FOR MARKET AUTHORIZATION AS EARLY AS
2021
    * UNIVERSAL VACCINATION REMAINS VERY HYPOTHETICAL; THIS
PREVENTIVE
TREATMENT SHOULD BE ESSENTIAL IN ALL SCENARIOS
    * THE TRIAL AIMS AT VALIDATING THE SAFETY OF CONTINUOUS
ADMINISTRATION OF IVERMECTIN IN ORAL FORM
    * A 1-MONTH ACTIVE INJECTABLE PROPHYLACTIC TREATMENT SHOULD
BE
READY TO ENTER REGULATORY DEVELOPMENT BEFORE END OF YEAR

Source text for Eikon:  ID:nNDL3Bpr7D 
Further company coverage:  MEDCL.PA 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))